HIV incidence estimation using the BED capture enzyme immunoassay: Systematic review and sensitivity analysis

Epidemiology

Volumn 21, Issue 5, 2010, Pages 685-697

  Bärnighausen, Till ^a,b   McWalter, Thomas A ^c   Rosner, Zachary ^b,d   Newell, Marie Louise ^b,e   Welte, Alex ^c,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BED IGG CAPTURE ENZYME IMMUNOASSAY; ENZYME IMMUNOASSAY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PARAMETER; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS;

CALIBRATION; CONFIDENCE INTERVALS; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 77954304458     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181e9e978     Document Type: Review

References (62)

1. Beyrer C, Nelson KE. Loss to follow-up effect in investigations of HIV-1 incidence. Lancet. 1997;349:649-650.
2. Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res. 2005;121:510-518.
3. McDougal JS, Pilcher CD, Parekh BS, et al. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS. 2005;19(suppl 2):S25-S30.
4. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 2008;13:pii:18966.
5. Suligoi B, Galli C, Massi M, et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol. 2002;40:4015-4020.
6. Barin F, Meyer L, Lancar R, et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol. 2005;43:4441-4447.
7. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey. Cape Town, South Africa: HSRC Press; 2005.
8. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in Uganda. JAMA. 2008;300:540-549.
9. Jiang Y, Wang M, Ni M, et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS. 2007;21(suppl 8):S47-S51.
10. Hu DJ, Vanichseni S, Mock PA, et al. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immuno-assay. AIDS Res Hum Retroviruses. 2003;19:727-730.
11. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18:295-307.
12. Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted? AIDS. 2009;23:485-491.
13. Hallett TB, Ghys P, Bärnighausen T, Yan P, Garnett GP. Errors in "BED"-derived estimates of HIV incidence will vary by place, time and age. PLoS One. 2009;4:e5720.
14. Welte A, McWalter TA, Bärnighausen T. Reply to "Should biomarker estimates of HIV incidence be adjusted?" AIDS. 2009;23:2062-2063.
15. McWalter TA, Welte A. A comparison of biomarker based incidence estimators. PLoS One. 2009;4:e7368.
16. Bärnighausen T, Wallrauch C, Welte A, et al. Comparison of HIV incidence and risk factors for recent infection based on longitudinal follow-up versus cross-sectional cBED assay testing: a study in rural South Africa. In: 16th Conference on Retroviruses and Opportunistic Infections (CROI); February 8-11, 2009; Montreal, Canada.
17. Bärnighausen T, Wallrauch C, Welte A, et al. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One. 2008;3:e3640.
18. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol. 1995;141:166-172.
19. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48.
20. McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses. 2006;22:945-952.
21. Hargrove JW, Humphrey JH, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS. 2008;22:511-518.
22. Welte A, McWalter TA, Bärnighausen T. A simplified formula for inferring HIV incidence from cross-sectional surveys using a test for recent infection. AIDS Res Hum Retroviruses. 2009;25:125-126.
23. McWalter TA, Welte A. Relating recent infection prevalence to incidence with a sub-population of assay non-progressors. J Math Biol. 2010;60:687-710.
24. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
25. Karon JM, Song R, Brookmeyer R, Kaplan EH, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med. 2008;27:4617-4633.
26. Li SW, Zhang XY, Li XX, et al. Detection of recent HIV-1 infections among men who have sex with men in Beijing during 2005-2006. Chin Med J (Engl). 2008;121:1105-1108.
27. Priddy FH, Pilcher CD, Moore RH, et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr. 2007;44:196-202.
28. Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS. 2007;21:403-408.
29. Verevochkin S, Masharsky A, Shaboltas A, Heimer R, Hoffman I, Kozlov A. Subtype A HIV-1 infection incidence estimates: differences between lab assays for detection of recent HIV infections and correlation with cohort studies among IDU in St. Petersburg, Russia. In: XVII International AIDS Conference; August 3-8, 2008; Mexico City, Mexico.
30. Wasinrapee P, Chaowanachan T, Martin M, et al. Estimation of HIV-1 incidence from a cross-sectional assessment of injecting drug users using the HIV-1 subtype BED IgG-capture EIA. In: XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand.
31. Bultreys M, Parekh BS, Chao A, et al. Use of an IgG capture BED enzyme immunoassay to investigate recent HIV-1 seroconversions among young women in Rwanda: comparison with 24-month prospective cohort data. Int Conf AIDS. 2004;15. Abstract no. MoPeC3458.
32. Kim A, McDougal S, Hargrove J, et al. Toward more plausible estimates of HIV-1 incidence in cross-sectional serologic surveys in Africa: application of a HIV-1 incidence assay with post-assay adjustments. In: 14th Conference on Retroviruses and Opportunistic Infections (CROI); February 25-28, 2007; Los Angeles, CA.
33. Gupta SB, Murphy G, Koenig E, et al. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic. AIDS Res Hum Retroviruses. 2007;23:1475-1480.
34. Saphonn V, Parekh BS, Dobbs T, et al. Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999-2002. J Acquir Immune Defic Syndr. 2005;39:587-592.
35. Welte A, McWalter TA, Laeyendecker O, Hallett TB. Using tests for recent infection to estimate incidence: problems and prospects for HIV. Euro Surveill. 2010;15:pii= 19589. Available at: http://www. eurosurveillance.org/ViewArticle. aspx?ArticleId= 19589.
36. Layendecker O. Measuring new HIV infections: where we are with new technologies and approaches measuring HIV incidence. BED + avidity testing algorithm. Presented at: The 2nd Global HIV/AIDS Surveillance Meeting; March 2-5, 2009; Bangkok, Thailand.
37. Brookmeyer R. Response to correspondence on "Should biomarker estimates of HIV incidence be adjusted"? AIDS. 2009;23:2066-2068.
38. Hargrove JW. BED estimates of HIV incidence must be adjusted. AIDS. 2009;23:2061-2062.
39. McDougal JS. BED estimates of HIV incidence must be adjusted. AIDS. 2009;23:2064-2065.
40. Apornpong T, Pankum T, Sirivichayakul S, et al. HIV incidence using BED testing among clients attending anonymous HIV testing site in Bangkok, Thailand. In: 4th IAS Conference on HIV Pathogenesis and Treatment and Prevention; July 22-25, 2007; Sydney, Australia.
41. Buchacz K, Klausner JD, Kerndt PR, et al. HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr. 2008;47:234-240.
42. Kana K, Tabprasit S, Chaitaveep P, Tienamporn P, Chuenchitra T. HIV-1 incidence estimates among Royal Thai Army conscripts: use of the IgG-capture BED-enzyme immunoassay. In: XVII International AIDS Conference; August 3-8, 2008; Mexico City, Mexico.
43. Nesheim S, Parekh B, Sullivan K, et al. Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses. 2005;21:537-544.
44. Plipat T, Teeraratkul A, Chalermchan W, et al. National HIV incidence surveillance using BED capture immunoassay among pregnant women and female sex workers, Thailand. In: XVI International AIDS Conference; August 13-18, 2006; Toronto, Canada.
45. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures\new insights into the South African epidemic. S Afr Med J. 2007;97:194-199.
46. Sakarovitch C, Rouet F, Murphy G, et al. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr. 2007;45:115-122.
47. Saphonn V, Shafer K, Kaldor J, et al. Risk factors and HIV incidence among voluntary counselling and testing site clients in Phnom Penh, Cambodia: 2006. In: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia.
48. Simbayi LC, Rehle T, Vass J, et al. The Impact of and Response to HIV/AIDS in the Private Security and Legal Services Industries in South Africa. Cape Town, South Africa: HSRC Press; 2007.
49. Sinthuwattaniwibool C, Wasinrapee P, Chaowanachan T, et al. Application of the BED-CEIA to a cohort of military conscripts in northern Thailand to estimate HIV-1 incidence: a validation study. In: 12th Conference on Retroviruses and Opportunistic Infections (CROI); February 22-25, 2005; Boston, MA.
50. Srikrishnan AK, Solomon SS, Vasudevan CK, et al. Incidence and prevalence of HIV and coinfections among injection drug users in Chennai, India\cause for concern. In: XVI International AIDS Conference; August 13-18, 2006; Toronto, Canada.
51. Truong HHM, Samnang P, Page-Shafer K, Louie B, McFarland W, Grant RM. Concordance of STARHS and BED assays for identifying recent HIV infections in Cambodian fishermen. In: XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand.
52. Truong HHM, Fritz K, McFarland W, Hartogenesis W, Fiamma A, Coates T, Morin S. Recent HIV infections detected at a mobile HIV voluntary counseling and testing program in Zimbabwe. In: 14th Conference on Retroviruses and Opportunistic Infections (CROI); February 25-28, 2007; Los Angeles, CA.
53. Truong HHM, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Comparison of HIV incidence estimates derived from laboratory incidence assays and repeat testing data at HIV testing sites in San Francisco. In: 14th Conference on Retroviruses and Opportunistic Infections (CROI); February 25-28, 2007; Los Angeles, CA.
54. Truong HHM, Mathur M, Mungekar S, et al. High rates of recent HIV-1 infections among male attendees of public STI clinics in Mumbai are associated with visits to commercial sex workers. In: XVII International AIDS Conference; August 3-8, 2008; Mexico City, Mexico.
55. Velasco de Castro CA, Grinsztejn B, Veloso V, et al. HIV-1 incidence, prevalence and social-demographic profile in VCTs of Rio de Janeiro State, Brazil. In: XVI International AIDS Conference; August 13-18, 2006; Toronto, Canada.
56. Velasco de Castro CA, Grinsztejn B, Veloso V, et al. Estimated HIV incidence and diversity among men who have sex with men (MSM) in VCTs of Rio de Janeiro State, Brazil. In: 4th IAS Conference on HIV Patho-genesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia.
57. Wang N, Xu JJ, Lu L, et al. Application of BED-CEIA and prospective cohort study for HIV incidence estimation among FSWs in Yunnan, China. In: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 22-25, 2007; Sydney, Australia.
58. Wang N, Xu J. Trends in HIV-incidence rates by the BED-CEIA/HIV pooled-PCR in a longitudinal cohort survey of FSWs of Kaiyuan city, China. In: XVII International AIDS Conference; August 3-8, 2008; Mexico City, Mexico.
59. Wasinrapee P, McNicholl J, Parekh B, McDougal S. Validation of HIV-1 incidence estimation with the Immunoglobulin G-capture BED-enzyme immunoassay (BED assay) in three longitudinal cohorts from Thailand. In: XVI International AIDS Conference; August 13-18, 2006; Toronto, Canada.
60. Wolday D, Meles H, Hailu E, et al. Temporal trends in the incidence of HIV infection in antenatal clinic attendees in Addis Ababa, Ethiopia, 1995-2003. J Intern Med. 2007;261:132-137.
61. Xiao Y, Jiang Y, Feng J, et al. Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol. 2007;14:1384-1386.
62. Centers for Disease Control and Prevention (CDC). BED-CEIA incidence and adjustment formula. 2006. Available at: http://www.cdc.gov/NCHSTP/OD/GAP/docs/ surveillance/BED-CEIA%20Incidence%20and% 20Adjustment%20Formula.pdf.